tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

KPRX Stock Latest News

Kiora Pharmaceuticals Gains Approval for Phase 2 Trial
Company AnnouncementsKiora Pharmaceuticals Gains Approval for Phase 2 Trial
8d ago
8K
KPRX
Kiora Pharmaceuticals target ajusted to $54 from $6 at Ladenburg
PremiumThe Fly
Kiora Pharmaceuticals target ajusted to $54 from $6 at Ladenburg
3M ago
KPRX
KPRX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
KPRX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
3M ago
KPRX
Kiora Pharmaceuticals Announces Board Appointment, Regains Nasdaq Compliance
PremiumCompany Announcements
Kiora Pharmaceuticals Announces Board Appointment, Regains Nasdaq Compliance
4M ago
8K
KPRX
Kiora Pharmaceuticals Inc trading halted, news pending
PremiumThe Fly
Kiora Pharmaceuticals Inc trading halted, news pending
5M ago
KPRX
Kiora Pharmaceuticals files to sell 76.53M shares of common stock for holders
PremiumThe FlyKiora Pharmaceuticals files to sell 76.53M shares of common stock for holders
8M ago
KPRX
Kiora Pharmaceuticals Unveils Updated Investor Presentation
Premium
Company Announcements
Kiora Pharmaceuticals Unveils Updated Investor Presentation
9M ago
8K
KPRX
Kiora Pharmaceuticals price target lowered to $2 from $3.50 at H.C. Wainwright
Premium
The Fly
Kiora Pharmaceuticals price target lowered to $2 from $3.50 at H.C. Wainwright
9M ago
KPRX
Kiora Pharmaceuticals Announces Securities Purchase Agreements
PremiumCompany Announcements
Kiora Pharmaceuticals Announces Securities Purchase Agreements
9M ago
8K
KPRX
Kiora Pharmaceuticals Reveals TOI Agreement and Presentation
PremiumCompany Announcements
Kiora Pharmaceuticals Reveals TOI Agreement and Presentation
9M ago
8K
KPRX
Kiora Pharmaceuticals Inc trading resumes
PremiumThe Fly
Kiora Pharmaceuticals Inc trading resumes
9M ago
KPRX
Kiora Pharmaceuticals Inc trading halted, news pending
PremiumThe Fly
Kiora Pharmaceuticals Inc trading halted, news pending
9M ago
KPRX
Kiora Pharmaceuticals price target raised to $3.50 from $2 at H.C. Wainwright
PremiumThe FlyKiora Pharmaceuticals price target raised to $3.50 from $2 at H.C. Wainwright
1y ago
KPRX
Kiora Pharmaceuticals price target lowered to $2 from $7 at H.C. Wainwright
Premium
The Fly
Kiora Pharmaceuticals price target lowered to $2 from $7 at H.C. Wainwright
1y ago
KPRX
Kiora Pharmaceuticals price target lowered to $2 from $12 at Maxim
Premium
The Fly
Kiora Pharmaceuticals price target lowered to $2 from $12 at Maxim
1y ago
KPRX
Kiora Pharmaceuticals price target lowered to $6 from $10 at H.C. Wainwright
PremiumThe Fly
Kiora Pharmaceuticals price target lowered to $6 from $10 at H.C. Wainwright
2y ago
KPRX
Kiora Pharmaceuticals upgraded to Buy at Maxim after IND approval for KIO-101
PremiumThe Fly
Kiora Pharmaceuticals upgraded to Buy at Maxim after IND approval for KIO-101
2y ago
KPRX
Kiora Pharmaceuticals received IND approval for Phase 2 study of KIO-101
PremiumThe Fly
Kiora Pharmaceuticals received IND approval for Phase 2 study of KIO-101
2y ago
KPRX
Kiora Pharmaceuticals upgraded to Buy from Hold at Maxim
PremiumThe Fly
Kiora Pharmaceuticals upgraded to Buy from Hold at Maxim
2y ago
KPRX
Ladenburg reiterates Buy on Kiora following Phase 2 KIO-101 OPRA+ IND clearance
PremiumThe FlyLadenburg reiterates Buy on Kiora following Phase 2 KIO-101 OPRA+ IND clearance
2y ago
KPRX
Kiora Soars on IND Approval for KIO-101 Eye Drops
Premium
Market News
Kiora Soars on IND Approval for KIO-101 Eye Drops
2y ago
KPRX
Kiora Pharmaceuticals completes enrollment in Phase 2 study, says Ladenburg
Premium
The Fly
Kiora Pharmaceuticals completes enrollment in Phase 2 study, says Ladenburg
2y ago
KPRX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >